|
18 Apr 2025 |
Laurus Labs
|
Consensus Share Price Target
|
628.05 |
520.07 |
- |
-17.19 |
hold
|
|
|
|
|
20 Oct 2023
|
Laurus Labs
|
Sharekhan
|
628.05
|
293.00
|
362.40
(73.30%)
|
|
Sell
|
|
|
|
|
31 Jul 2023
|
Laurus Labs
|
Keynote Capitals Ltd
|
628.05
|
402.00
|
352.00
(78.42%)
|
Target met |
Buy
|
|
|
Quarterly Update Q1FY24
|
|
02 May 2023
|
Laurus Labs
|
Keynote Capitals Ltd
|
628.05
|
383.00
|
311.60
(101.56%)
|
Target met |
Buy
|
|
|
Quarterly Update Q4FY23
|
|
28 Apr 2023
|
Laurus Labs
|
ICICI Direct
|
628.05
|
300.00
|
307.60
(104.18%)
|
Target met |
Hold
|
|
|
|
|
31 Mar 2023
|
Laurus Labs
|
Keynote Capitals Ltd
|
628.05
|
396.00
|
292.95
(114.39%)
|
Target met |
Buy
|
|
|
Initiating Coverage Report
|
|
31 Jan 2023
|
Laurus Labs
|
ICICI Direct
|
628.05
|
400.00
|
330.30
(90.15%)
|
Target met |
Buy
|
|
|
|
|
30 Jan 2023
|
Laurus Labs
|
Motilal Oswal
|
628.05
|
440.00
|
341.80
(83.75%)
|
Target met |
Buy
|
|
|
|
|
22 Oct 2022
|
Laurus Labs
|
BOB Capital Markets Ltd.
|
628.05
|
540.00
|
486.25
(29.16%)
|
|
Hold
|
|
|
Q2 revenue grew 31% YoY (+2% QoQ) led by synthesis division and other APIs; FDF revenue at record-low of Rs 1.5bn
|
|
22 Oct 2022
|
Laurus Labs
|
ICICI Direct
|
628.05
|
630.00
|
486.25
(29.16%)
|
|
Buy
|
|
|
|
|
28 Jul 2022
|
Laurus Labs
|
ICICI Direct
|
628.05
|
675.00
|
525.25
(19.57%)
|
|
Buy
|
|
|
|